Burstein Jennifer is a director of Stoke Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Stoke Therapeutics, Inc.
15 Jun 23
4
Stoke Therapeutics, Inc.
8 Jun 22
4
Stoke Therapeutics, Inc.
25 Jun 21
4
Stoke Therapeutics, Inc.
5 Jun 20
4
Stoke Therapeutics, Inc.
12 Sep 19
3
Stoke Therapeutics, Inc.
19 Jun 19
4
Loxo Oncology, Inc.
15 Feb 19
4
Loxo Oncology, Inc.
2 Jan 19
4
Loxo Oncology, Inc.
12 Dec 18
4
Loxo Oncology, Inc.
28 Nov 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 23 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 12.46 | 19,441 | 242.23 k | 19,441 |